Canada Pension Plan Investment Board
CTMX icon

Canada Pension Plan Investment Board’s CytomX Therapeutics CTMX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$531K Buy
141,500
+32,700
+30% +$125K ﹤0.01% 1243
2026
Q1 		$511K Buy
108,800
+4,600
+4% +$23.3K ﹤0.01% 1229
2025
Q4 		$444K Buy
+104,200
New +$396K ﹤0.01% 1344

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Canada Pension Plan Investment Board's CTMX Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its CytomX Therapeutics (CTMX) stake by 30% in Q2 2026, buying an estimated $125K and bringing the position to 141,500 shares worth $531K. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Canada Pension Plan Investment Board first reported a position in CTMX in Q4 2025 and has held it in 3 quarters since. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Canada Pension Plan Investment Board held 141,500 shares of CytomX Therapeutics worth $531K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 32,700 CytomX Therapeutics shares in Q2 2026, an estimated $125K.
  • CytomX Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1243 holding.
  • Canada Pension Plan Investment Board first reported a position in CytomX Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.